S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
S&P 500   3,426.92 (-1.63%)
DOW   28,195.42 (-1.44%)
QQQ   283.80 (-1.63%)
AAPL   115.98 (-2.55%)
MSFT   214.22 (-2.48%)
FB   261.40 (-1.70%)
GOOGL   1,529.95 (-2.41%)
AMZN   3,207.21 (-2.00%)
TSLA   430.83 (-2.01%)
NVDA   539.91 (-2.27%)
BABA   305.29 (-0.66%)
CGC   19.81 (+11.54%)
GE   7.29 (+0.00%)
MU   52.63 (+1.98%)
AMD   82.00 (-1.41%)
T   26.88 (-1.65%)
F   7.59 (-1.04%)
ACB   4.71 (+17.16%)
GILD   60.57 (-2.31%)
NFLX   530.72 (-0.01%)
BA   167.11 (-0.14%)
BAC   23.72 (-2.15%)
DIS   124.23 (-2.03%)
Log in
NASDAQ:WVE

Wave Life Sciences Stock Forecast, Price & News

$8.41
-0.51 (-5.72 %)
(As of 10/19/2020 12:00 AM ET)
Add
Compare
Today's Range
$8.37
Now: $8.41▼
$9.04
50-Day Range
$8.04
MA: $11.70▼
$19.54
52-Week Range
$6.61
Now: $8.41▼
$39.98
Volume783,669 shs
Average Volume772,655 shs
Market Capitalization$306.58 million
P/E RatioN/A
Dividend YieldN/A
Beta0.19
Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces of novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. The company is primarily developing oligonucleotides that target genetic defects to either reduce the expression of disease-promoting proteins or transform the production of dysfunctional mutant proteins into the production of functional proteins. It focuses on programs in neurology in the central nervous system and neuromuscular system. The company has a research, license, and option agreement with Pfizer Inc. and Takeda Pharmaceutical Company Limited for the research, development, and commercialization of stereopure oligonucleotide therapeutics and oligonucleotide therapeutics; and research, development, and develop antisense oligonucleotides. Wave Life Sciences Ltd. was founded in 2012 and is based in Singapore.
Read More
Wave Life Sciences logo

Beat the Market (BTM) Rank™

Analyst Opinion: 3.3Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 2.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank™

1.73 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NASDAQ
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:WVE
Previous Symbol
CUSIPN/A
CIK1631574
Webwww.wavelifesciences.com
Phone65-6236-3388
Employees301

Debt

Debt-to-Equity Ratio1.36
Current Ratio1.33
Quick Ratio1.33

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$15.98 million
Price / Sales19.19
Cash FlowN/A
Price / Cash FlowN/A
Book Value$1.86 per share
Price / Book4.52

Profitability

EPS (Most Recent Fiscal Year)($5.72)
Net Income$-193,640,000.00
Net Margins-1,562.01%
Return on Equity-401.32%
Return on Assets-72.82%

Miscellaneous

Outstanding Shares36,454,000
Market Cap$306.58 million
Next Earnings Date11/3/2020 (Estimated)
OptionableOptionable
$8.41
-0.51 (-5.72 %)
(As of 10/19/2020 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive WVE News and Ratings via Email

Sign-up to receive the latest news and ratings for WVE and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Wave Life Sciences (NASDAQ:WVE) Frequently Asked Questions

How has Wave Life Sciences' stock price been impacted by COVID-19 (Coronavirus)?

Wave Life Sciences' stock was trading at $8.12 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, WVE shares have increased by 3.6% and is now trading at $8.41.
View which stocks have been most impacted by COVID-19.

Do Wall Street analysts recommend investors buy shares of Wave Life Sciences?

6 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Wave Life Sciences in the last year. There are currently 2 hold ratings and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Wave Life Sciences.

When is Wave Life Sciences' next earnings date?

Wave Life Sciences is scheduled to release its next quarterly earnings announcement on Tuesday, November 3rd 2020.
View our earnings forecast for Wave Life Sciences.

How were Wave Life Sciences' earnings last quarter?

Wave Life Sciences Ltd. (NASDAQ:WVE) issued its earnings results on Monday, August, 10th. The company reported ($1.15) earnings per share for the quarter, missing the consensus estimate of ($1.03) by $0.12. The firm had revenue of $3.03 million for the quarter, compared to the consensus estimate of $7.04 million. Wave Life Sciences had a negative return on equity of 401.32% and a negative net margin of 1,562.01%.
View Wave Life Sciences' earnings history.

What price target have analysts set for WVE?

6 brokers have issued 1 year price objectives for Wave Life Sciences' stock. Their forecasts range from $10.00 to $27.00. On average, they expect Wave Life Sciences' share price to reach $20.50 in the next year. This suggests a possible upside of 143.8% from the stock's current price.
View analysts' price targets for Wave Life Sciences.

Who are some of Wave Life Sciences' key competitors?

Some companies that are related to Wave Life Sciences include Mersana Therapeutics (MRSN), Generation Bio (GBIO), Theravance Biopharma (TBPH), Cytokinetics (CYTK), Nabriva Therapeutics (NBRV), Karyopharm Therapeutics (KPTI), NGM Biopharmaceuticals (NGM), Zogenix (ZGNX), Applied Molecular Transport (AMTI), Constellation Pharmaceuticals (CNST), Retrophin (RTRX), Phathom Pharmaceuticals (PHAT), Intercept Pharmaceuticals (ICPT), Indivior (INVVY) and Supernus Pharmaceuticals (SUPN).
View all competitors.

What other stocks do shareholders of Wave Life Sciences own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Wave Life Sciences investors own include Gilead Sciences (GILD), Exelixis (EXEL), Sangamo Therapeutics (SGMO), Sorrento Therapeutics (SRNE), TherapeuticsMD (TXMD), VBI Vaccines (VBIV), Aduro BioTech (ADRO), Cidara Therapeutics (CDTX), Crispr Therapeutics (CRSP) and ImmunoGen (IMGN).

Who are Wave Life Sciences' key executives?

Wave Life Sciences' management team includes the following people:
  • Dr. Paul B. Bolno M.B.A., M.D., MBA, Pres, CEO & Director (Age 46, Pay $881.53k)
  • Dr. Chandra Vargeese, Chief Technology Officer (Age 59, Pay $564.52k)
  • Dr. Michael A. Panzara M.P.H., M.D., MPH, Chief Medical Officer and Head of Therapeutics Discovery & Devel. (Age 53, Pay $597k)
  • Mr. David G. Gaiero, Interim Chief Financial Officer (Age 42)
  • Mr. Kyle B. Moran, Sr. VP of Fin. & Operations (Age 49)

What is Wave Life Sciences' stock symbol?

Wave Life Sciences trades on the NASDAQ under the ticker symbol "WVE."

How do I buy shares of Wave Life Sciences?

Shares of WVE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Wave Life Sciences' stock price today?

One share of WVE stock can currently be purchased for approximately $8.41.

How big of a company is Wave Life Sciences?

Wave Life Sciences has a market capitalization of $306.58 million and generates $15.98 million in revenue each year. The company earns $-193,640,000.00 in net income (profit) each year or ($5.72) on an earnings per share basis. Wave Life Sciences employs 301 workers across the globe.

What is Wave Life Sciences' official website?

The official website for Wave Life Sciences is www.wavelifesciences.com.

How can I contact Wave Life Sciences?

Wave Life Sciences' mailing address is 7 STRAITS VIEW #12-00 MARINA ONE EAST TOWER, SINGAPORE U0, 018936. The company can be reached via phone at 65-6236-3388 or via email at [email protected]

This page was last updated on 10/19/2020 by MarketBeat.com Staff
Receive Analysts' Upgrades and Downgrades Daily

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.